fingolimod hydrochloride has been researched along with Cognition Disorders in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| de Chalus, A; Deiva, K; Taveira, M | 1 |
| Amato, MP; Bartezaghi, M; Bergh, FT; Centonze, D; Comi, G; Filippi, M; Gallo, P; Mattioli, FC; Patti, F; Pozzilli, C; Rocca, MA; Saccà, F; Turrini, R | 1 |
| Campos, MM; da Costa, JC; Gomez, MV; Greggio, S; Silva, RBM; Venturin, GT | 1 |
| Guerrero, M; Roberts, E; Rosen, H; Urbano, M | 1 |
| Bendix, I; Felderhoff-Müser, U; Hadamitzky, M; Hansen, W; Herrmann, R; Herz, J; Heumann, R; Hou, X; Kempe, K; Lumpe, K; Reinboth, BS; Serdar, M; Sifringer, M; Sizonenko, SV; van de Looij, Y | 1 |
| Becker-Krail, D; Boger, HA; Farrand, AQ; Lavin, A | 1 |
| Cardani, AN; Crihfield, A; Derecki, NC; Kipnis, J; Lynch, KR; Quinnies, KM; Yang, CH | 1 |
2 review(s) available for fingolimod hydrochloride and Cognition Disorders
| Article | Year |
|---|---|
Pediatric onset multiple sclerosis: Future challenge for early diagnosis and treatment.
Topics: Adolescent; Age of Onset; Child; Child, Preschool; Cognition Disorders; Demyelinating Autoimmune Diseases, CNS; Diagnosis, Differential; Early Diagnosis; Female; Fingolimod Hydrochloride; Humans; Immunologic Factors; Infant; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Natalizumab; Sphingosine 1 Phosphate Receptor Modulators; Symptom Assessment | 2021 |
Sphingosine 1-phosphate receptor agonists: a patent review (2010-2012).
Topics: Animals; Bradycardia; Cognition Disorders; Drug Design; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Multiple Sclerosis, Relapsing-Remitting; Patents as Topic; Propylene Glycols; Receptors, Lysosphingolipid; Sphingosine | 2013 |
1 trial(s) available for fingolimod hydrochloride and Cognition Disorders
| Article | Year |
|---|---|
Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing-remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study).
Topics: Adolescent; Adult; Cognition Disorders; Depression; Disability Evaluation; Electrocardiography; Executive Function; Female; Fingolimod Hydrochloride; Humans; Immunologic Factors; Interferon beta-1b; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Neuropsychological Tests; Pilot Projects; Statistics, Nonparametric; Treatment Outcome; Young Adult | 2017 |
4 other study(ies) available for fingolimod hydrochloride and Cognition Disorders
| Article | Year |
|---|---|
Beneficial Effects of the Calcium Channel Blocker CTK 01512-2 in a Mouse Model of Multiple Sclerosis.
Topics: Animals; Anti-Inflammatory Agents; Calcium Channel Blockers; Chemokines; Cognition Disorders; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Fingolimod Hydrochloride; Hyperalgesia; Inflammation; Inflammation Mediators; Injections, Spinal; Mice, Inbred C57BL; Motor Activity; Multiple Sclerosis; Myelin Sheath; Myelin-Oligodendrocyte Glycoprotein; Nociception; omega-Conotoxins; Peptide Fragments | 2018 |
Fingolimod protects against neonatal white matter damage and long-term cognitive deficits caused by hyperoxia.
Topics: Animals; Animals, Newborn; Brain; Cognition Disorders; Diffusion Magnetic Resonance Imaging; Female; Fingolimod Hydrochloride; Hyperoxia; Lysophospholipids; Male; Microglia; Nerve Fibers, Myelinated; Oligodendroglia; Oxygen; Pregnancy; Random Allocation; Rats; Rats, Wistar; Receptors, Lysosphingolipid; Sphingosine; White Matter | 2016 |
Effects of fingolimod administration in a genetic model of cognitive deficits.
Topics: Animals; Brain-Derived Neurotrophic Factor; Calcium; Cerebral Cortex; Cognition Disorders; Disease Models, Animal; Dysbindin; Enzyme-Linked Immunosorbent Assay; Fingolimod Hydrochloride; Gene Expression Regulation; Immunosuppressive Agents; Male; Memory; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Social Behavior; Synaptosomes | 2017 |
Regulation of learning and memory by meningeal immunity: a key role for IL-4.
Topics: Animals; Bone Marrow Transplantation; Cognition Disorders; Fingolimod Hydrochloride; Immunosuppressive Agents; Interleukin-4; Learning; Lymphocyte Depletion; Meninges; Mice; Mice, Inbred BALB C; Mice, Knockout; Propylene Glycols; Sphingosine; T-Lymphocytes | 2010 |